BioCentury
ARTICLE | Company News

Arius, Fusion Antibodies deal

March 5, 2007 8:00 AM UTC

Fusion will use its Fusion Expression Technology (FET) high-throughput screening platform to engineer new recombinant antibodies for ARI to treat cancer. Financial terms were not disclosed. ...